Stock MDGL MADRIGAL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Madrigal Pharmaceuticals, Inc.

Equities

MDGL

US5588681057

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/05/2024 BST 		5-day change 1st Jan Change
217.2 USD +2.57% Intraday chart for Madrigal Pharmaceuticals, Inc. +4.95% -6.14%
05-10 B. Riley Cuts Madrigal Pharmaceuticals' Price Target to $200 From $270, Keeps Neutral Rating MT
05-09 UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MADRIGAL PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+2.57%+4.95%-6.14%-25.68%+103.71% 4.51B
Neutral
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MDGL Stock
  4. Charts Madrigal Pharmaceuticals, Inc.
  5. Comparison Chart